Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "non"

1703 News Found

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


DENSTAR project launched to fast-track dengue vaccine licensure in Africa
Healthcare | June 09, 2026

DENSTAR project launched to fast-track dengue vaccine licensure in Africa

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa


FDA expands Pfizer’s HYMPAVZI approval
Drug Approval | June 09, 2026

FDA expands Pfizer’s HYMPAVZI approval

Broadening access for children & patients with inhibitor-complicated hemophilia


Smile Foundation delivers 20 lakh healthcare treatments in FY26
Healthcare | June 08, 2026

Smile Foundation delivers 20 lakh healthcare treatments in FY26

Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006


Dr. Prahlad Agrawal appointed as COO of Yatharth Super Speciality Hospital, Noida Extension
People | June 08, 2026

Dr. Prahlad Agrawal appointed as COO of Yatharth Super Speciality Hospital, Noida Extension

Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role


BPL MedTech unveils new ICU ventilator BPL Vent 300
Medical Device | June 04, 2026

BPL MedTech unveils new ICU ventilator BPL Vent 300

The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow


ResMed acquires Noctrix Health for $340 million
Medical Device | June 04, 2026

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio


FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG
Drug Approval | June 02, 2026

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death


BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
Clinical Trials | June 02, 2026

BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial

The safety profile was described as manageable, though not without notable toxicities


Eli Lilly drug slashes lung cancer recurrence risk by 83% in landmark phase 3 trial
Clinical Trials | June 02, 2026

Eli Lilly drug slashes lung cancer recurrence risk by 83% in landmark phase 3 trial

The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)